Asthma Research Papers

13461 Issued in October 2007 NBER Program(s): Children, Health Care Background: Family structure is known to influence children's behavioral, educational, and cognitive outcomes, and recent studies suggest that family structure affects children's access to health care as well.However, no study has addressed whether family structure is associated with the care children receive for particular conditions or with their physical health outcomes.The CDC recently revealed that the prevalence of asthma between 20 increased in the US population from 7.3% (20.3 million individuals) to 8.2% (24.6 million individuals), representing a 12.3% increase.

Tags: Thesis On Advertising CampaignsEnder'S Essay Question TopicsHills Like White Elephants Analysis EssayAgruementative ThesisGraphic Organizers For Writing EssaysEmployee Engagement Dissertation QuestionsSp Jain Gmba EssayMilitary Assignment OrdersEconomic Possibilities For Our Grand Essays In Persuasion

Our regression models adjusted for sociodemographic characteristics, parental experience in child-rearing and in caring for an asthmatic child and, when appropriate, measures of children's health status.

Results: Asthmatic children in single-mother families had fewer office visits for asthma and filled fewer prescriptions for controller medications than children with two parents.

The study samples consisted of children 2-17 years of age with asthma who lived in single-mother or two-parent families.

We assessed the effect of number of parents and number of other children in the household on office visits for asthma and use of asthma medications using negative binomial regression, and we assessed the effect of family structure on the severity of asthma symptoms using binary and ordinal logistic regression.

A positive result in the methacholine challenge is defined as the dose of methacholine that causes a decrease in forced expiratory volume in 1 second (FEV Aridol (mannitol inhalation powder; Pharmaxis Ltd, Frenchs Forest, Australia) is now available as a bronchial challenge test kit for the assessment of bronchial hyperresponsiveness.

This indirect test offers the advantages of office administration, ease of use, and lower cost than the methacholine challenge.

Salmeterol, formoterol, and aformoterol are the 3 formulations of LABAs currently approved for use in the United States.

These agents are not indicated for single use in the treatment of asthma and should always be combined with an ICS.

Asthma is a clinical syndrome that typically consists of increased airway hyperresponsiveness and recurrent episodes of airway obstruction and inflammation with subsequent remodeling.

As one of the most common conditions seen in the primary care setting, asthma is of great interest to the US Centers for Disease Control and Prevention (CDC).